Mehr lesen
Economic Evaluation of Pharmacy Services provides the latest on the trend to a more product-centered and service-centered practice, eschewing traditional economic evaluation techniques that focus on product-to-product comparisons in favor of evaluating processes that measure costs and health outcomes.
Complete with examples focusing on best practices, including various study designs, types of pharmacy services, and types of outcomes being evaluated, the book emphasizes case studies and examples that help readers understand economic evaluation techniques. Many of these techniques are transferable across countries, especially where there are advanced and stable health systems in place. With the help of this practical guide, readers will gain a thorough understanding of the application of economic evaluation of pharmacy services.
Inhaltsverzeichnis
1. An Introduction to Economic Evaluation of Health Care Programs2. Economic Evaluation of Community and Hospital Pharmacy Services: An Introductory Review3. Economic Evaluation of Pharmacy Services: Review of Studies From Asia, Africa, and South America4. Economic Evaluation and Its Types5. Design Principles for Economic Evaluations in Pharmacy6. Steps in Conducting an Economic Evaluation7. Evaluation of the Community Pharmacist-led Anticoagulation Management Service (CPAMS) Pilot Program in New Zealand8. Economic Evaluation of Pharmacy Services in Portugal9. Economic Evaluation of Pharmacist-Managed Warfarin Therapy: A Review of Studies10. Economic Evaluation of a Medicines Management Model in New Zealand: A Proposal
Über den Autor / die Autorin
With over 25 years of experience in pharmaceutical policy and practice research, Prof Zaheer Babar is a global authority and a prolific author in this field. He comes with a long-standing academic career in pharmacy in New Zealand, and the United Kingdom. He is globally known for his work in policy and practice, including quality use of medicines, and issues related to medicines access and pricing.
Prof. Babar has published over 300 papers and is considered the leading researcher in the “pharmacy practice research category”. He has published in high-impact journals such as PLoS Medicine and the Lancet and has acted as a consultant for the WHO, RPS, UNDP, HAI, MSH, FIP, International Union Against Tuberculosis and Lung Disease, World Bank, European Union, and the Pharmaceutical Management Agency of New Zealand. His edited work includes "Economic Evaluation of Pharmacy Services", "Pharmaceutical Prices in the 21st Century", "Pharmaceutical Policies in Countries with Developing Healthcare Systems", "Global Pharmaceutical Policy", "Access to high-cost medicines", "Pharmacy Practice Research Methods", "Pharmacy Practice Research Case Studies" , "Encyclopaedia of Pharmacy Practice and Clinical Pharmacy", and "Encyclopaedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy". Published by Elsevier and Adis/Springer, his work is used in curriculum design, policy development, and referral all around the globe. Professor Babar is the founding Editor-In-Chief of the Journal of Pharmaceutical Policy and Practice [IF = 4.2], a high-impact publication that provides evidence-based insights and recommendations for policymakers, practitioners, and researchers. He can be contacted at: z.babar@hud.ac.uk
Bericht
"...the contribution of the book is important. Particularly welcomed by this reviewer is the book's comprehensive approach in presenting studies from a variety of countries and health systems." --Research in Social and Administrative Pharmacy
"This book provides much needed knowledge in current pharmacy practice. Furthermore, it provides up-to-date information and evaluation of innovative pharmacy services in different countries." --Minji Sohn, Ferris State University
"At a time of expanding scopes of practice within the profession of pharmacy, and the increasing demand by payers, patients, and other health professions to justify the allocation of scarce resources toward new pharmacy services, methodologically sound examples of effectiveness and cost-effectiveness are essential. In this manner, the contribution of the book is important. Particularly welcomed by this reviewer is the book's comprehensive approach in presenting studies from a variety of countries and health systems. As an educator, it is often a challenge to provide examples of pharmaco-economic studies beyond North America and Western Europe." --Roy Thomas Dobson, University of Saskatchewan, Canada, for journal of Research in Social and Administrative Pharmacy
